Pyrimethamine-sulphadoxine: how great the risk?
作者信息
Stürchler D
出版信息
J R Soc Med. 1990 Sep;83(9):598-9. doi: 10.1177/014107689008300926.
Abstract
摘要
相似文献
1
Pyrimethamine-sulphadoxine: how great the risk?乙胺嘧啶-磺胺多辛：风险有多大？
J R Soc Med. 1990 Sep;83(9):598-9. doi: 10.1177/014107689008300926.
2
Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia.马来西亚沙巴州的严重皮肤不良反应与周效磺胺-乙胺嘧啶
Med J Aust. 1987 Mar 16;146(6):335-6. doi: 10.5694/j.1326-5377.1987.tb120285.x.
3
Intermittent preventive treatment during pregnancy with sulphadoxine-pyrimethamine may promote Plasmodium falciparum gametocytogenesis.孕妇用磺胺多辛-乙胺嘧啶间歇性预防治疗可能会促进疟原虫配子体形成。
Med Princ Pract. 2012;21(1):63-7. doi: 10.1159/000332405. Epub 2011 Oct 21.
4
Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.瑞典旅行者对周效磺胺-乙胺嘧啶的不良反应：对预防措施的启示
Br Med J (Clin Res Ed). 1987 Aug 8;295(6594):365-6. doi: 10.1136/bmj.295.6594.365-a.
5
Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.用周效磺胺-乙胺嘧啶治疗恶性疟后出现的锥体外系综合征。
Saudi Med J. 2004 Sep;25(9):1303-4.
6
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.青蒿琥酯联合乙胺嘧啶-磺胺多辛治疗冈比亚儿童单纯性疟疾的疗效：一项双盲、随机、对照试验。
Lancet. 2000 Jan 29;355(9201):352-7. doi: 10.1016/S0140-6736(99)10237-X.
7
Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment.注射用周效磺胺-乙胺嘧啶（Fansidar）：一种有效且安全但未得到充分使用的抗疟治疗方法。
Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):641-3. doi: 10.1016/0035-9203(90)90131-w.
8
Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).乙胺嘧啶-磺胺多辛（Fansidar）导致的致命性肝坏死。
Ann Intern Med. 1987 Mar;106(3):393-5. doi: 10.7326/0003-4819-106-3-393.
9
Fansidar hypersensitivity pneumonitis.Fansidar诱发的过敏性肺炎。
Br J Dis Chest. 1987 Apr;81(2):194-6. doi: 10.1016/0007-0971(87)90140-9.
10
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.阿莫地喹联合磺胺多辛-乙胺嘧啶单独或联合用于孕期疟疾治疗的疗效、安全性及耐受性：一项随机试验
Lancet. 2006 Oct 14;368(9544):1349-56. doi: 10.1016/S0140-6736(06)69559-7.
引用本文的文献
1
How frequent are notified severe cutaneous adverse reactions to Fansidar?法西达引起的严重皮肤不良反应报告的频率如何？
Drug Saf. 1993 Feb;8(2):160-8. doi: 10.2165/00002018-199308020-00006.
本文引用的文献
1
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.用乙胺嘧啶-磺胺多辛预防艾滋病患者卡氏肺孢子虫感染。
Lancet. 1984 Aug 18;2(8399):398-9. doi: 10.1016/s0140-6736(84)90560-9.
2
Antagonism of chloroquine with other antimalarials.氯喹与其他抗疟药的拮抗作用。
Trans R Soc Trop Med Hyg. 1988;82(2):221. doi: 10.1016/0035-9203(88)90417-8.
3
Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者中贝氏等孢球虫感染的治疗与预防
N Engl J Med. 1989 Apr 20;320(16):1044-7. doi: 10.1056/NEJM198904203201604.
4
Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.瑞士出现的对磺胺多辛-乙胺嘧啶的严重皮肤不良反应。
Lancet. 1986 Mar 15;1(8481):610. doi: 10.1016/s0140-6736(86)92825-4.
5
Does chloroquine contribute to the risk of serious adverse reactions to fansidar?氯喹会增加使用 Fansidar 产生严重不良反应的风险吗？
Lancet. 1985 Dec 7;2(8467):1298-9. doi: 10.1016/s0140-6736(85)91574-0.
6
Malaria prophylaxis in travellers from Britain.来自英国的旅行者的疟疾预防
J Infect. 1989 May;18(3):209-12. doi: 10.1016/s0163-4453(89)80056-8.
7
Current recommendations and future prospects in the treatment of toxoplasmosis.弓形虫病治疗的当前建议与未来前景
Drugs. 1989 Dec;38(6):973-87. doi: 10.2165/00003495-198938060-00008.
8
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.胎儿弓形虫病：宫内治疗后的妊娠结局及婴儿随访
J Pediatr. 1989 Nov;115(5 Pt 1):765-9. doi: 10.1016/s0022-3476(89)80660-2.
Zotero 插件